期刊文献+

系统性硬化病68例临床分析 被引量:2

Clinical analysis of 68 patients with systemic sclerosis
暂未订购
导出
摘要 目的 :探讨系统性硬化病 (systemicsclerosis ,SSc)的临床表现 ,提高对SSc的认识。方法 :对 6 8例SSc患者的临床和实验室资料进行回顾性分析。结果 :男女之比为 1∶5 .8,平均发病年龄 37.13± 14 .6 1岁 ;所有患者均有不同程度的皮肤改变 ,雷诺现象 5 3例 (77.94 % ) ,内脏器官受累 4 6例 (6 7.65 % ) ;γ球蛋白升高占 87.2 3% (4 1/ 4 7) ,ANA阳性率 5 9.0 2 % (36 / 6 1) ;与局限型组比较 ,弥漫型组雷诺现象发生较少 (P =0 .0 17) ,而出现关节畸形、内脏受损、白细胞增多及血沉增快者较多 (均P <0 .0 5 ) ;抗Scl- 70阳性率 14 .5 8% (7/ 4 8)且只见于弥漫型组 ,抗RNP阳性率 14 .5 8% (7/ 4 8)且只见于有雷诺现象患者 ;6例死亡者均为弥漫型 ,均死于心、肺、肾等合并症。结论 :SSc常累及多个系统器官 ,并存在多种免疫学异常 ;弥漫型SSc内脏受累较多、较重 ,预后差 ;早期诊治是改善SSc预后的关键。 Objective: To explore the clinical and immunological features of systemic sclerosis (SSc). Methods: The clinical and laboratory data of 68 patients with SSc were analyzed retrospectively. Results: There were 10 male and 58 female(1: 5.8) in this study with mean onset age of (37.13±14.61) years. There were skin damages of different degrees in all patients. Raynaud's phenomenon were presents in 53patients (77.94%), and internal organ involvement in 46 patients (67.65%). The positive rates of elevated ESR, elevated γ-globulin, ANA were 65.08%(41/63), 87.23%(41/47) and 59.02%(36/61), respectively. Compared with the limit SSc group, the cases of Raynaud's phenomenon were less, and the cases of joint malformation, internal organ involvement, leukocytosis and elevated ESR were more in diffuse SSc group (all P<0.05). Anti-Scl-70 were only found in diffuse SSc, and Anti-RNP were only found in cases with Raynaud's phenomenon. All 6 died patients were diffuse SSc. Conclusion: The patients of SSc present several systemic involvements and immunological abnormalities. The diffuse SSc may be more internal organ involvements, more severe, more progressive and poor prognosis. Early diagnosis and treatment was the key point for the prognosis improvement of SSc.
出处 《河北医学》 CAS 2003年第6期508-512,共5页 Hebei Medicine
关键词 系统性硬化病 临床分析 诊断 治疗 免疫学 预后 Sclerosis systemic Immunology Prognosis
  • 相关文献

参考文献11

  • 1谭庆梅,翁孟武,苏炜.系统性硬皮病患者血清ENA多肽抗体与临床的关系[J].临床皮肤科杂志,2000,29(1):16-17. 被引量:5
  • 2王万卷,马韵琴,刘丹亚,张盘谏,陈庆秀.抗Scl-70和抗Jo-1抗体在系统性硬皮病和皮肌炎中的临床意义[J].中国皮肤性病学杂志,1998,12(2):80-81. 被引量:2
  • 3金丕焕.生存率统计[A]..医用统计方法[C].上海:上海医科大学出版社,1993.309—325.
  • 4杨旭燕,黄次波.系统性硬化症的抗Ro/SSA抗体检测[J].中华皮肤科杂志,1997,30(1):35-36. 被引量:1
  • 5Subcommittee for scleroderma criteria of the American Rheumatism Associations Diagnostic and Therapeutic Criteria Committee[J]. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Pdaeum, 1980,23(4) :581 - 590.
  • 6Gabriele V, Carol B. Systemic sclerosis [ J]. Clin Rheum.2002, 16(5) :807 - 816.
  • 7Frank CA, Robert FH, Filemon T, et al. Increased prevalence of systemic sclerosis in a native American tribe in Oklahoma[J].Arthritis Rheum, 1996,39(8):1362- 13.70.
  • 8Roger H, Agneta S, Anita A. Mortality and causes of death in a Swedish series of systemic sclerosis patients [ J ]. Ann Rheum Dis, 1998, 57:682 - 686.
  • 9Mayes MD. Scleroderma epidemiology [ J ]. Rheum Dis Clin North Am, 1996; 22:751 - 764.
  • 10Tunothy JL, Brenda WG, Mary BT, et al. Racial differences in scleroderma among women in Michigan[J]. Arthritis Rheum,1997,20(4) :734 - 742.

二级参考文献6

共引文献5

同被引文献12

  • 1贾丽梅,曲艺.系统性硬皮病112例临床分析[J].中国皮肤性病学杂志,2004,18(12):726-727. 被引量:10
  • 2于慧敏,张凤山.系统性硬化症发病机制研究进展[J].中华风湿病学杂志,2005,9(6):362-365. 被引量:13
  • 3赖松青.系统性硬皮病105例临床分析[J].临床皮肤科杂志,1997,26(1):14-16. 被引量:8
  • 4Poormoghim H, Lucas M, Fertig N, et al. Systemic sclerosis sine scloroderma demographic, clinical, andserologic features and survival in forty-eight patients. Arthritis Rheum, 2000, 43: 444- 445.
  • 5麦垚 刘湘源.系统性硬化症134例床分析.Chinese General Praetice,2001,4(3):246-246.
  • 6Gilmar F P, Richard P A, Virgina M F, et al. Sleep disruption in systemic sclerosis (seleroderma) patients: clinical and polysomnographic findings [J]. Sleep Medicine, 2002, 3. 341 - 345.
  • 7郑红梅 邓紫玉.系统性硬化症40例临床分析.中国医药指南,2004,2(9):685-686.
  • 8Predrag Ostojic, Nemanja Damjanov. Different clinical features in patients with limited and diffuse cutaneous systemic sclerosis [J]. Clin Rheumatol, 2005, Nov (1) : 1 - 5.
  • 9D. Villalta, N. Bizzaro, S. Platzgummer, et al. Accuracy of semiquantitative immunoenzymatic methods in quantitation of antitopoisomerase Ⅰ (Scl-70) antibodies [J]. Clin Rheumatol, 2005, 24: 453 - 459.
  • 10杜宇,刘国宪,杨西群.60例系统性硬皮病分析[J].泸州医学院学报,1999,22(6):530-531. 被引量:1

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部